Stock Information
Replimune Group Inc (REPL)
Ticker Symbol: REPL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $694.44 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.4362
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -102.69%
Latest News
-
The trading volume of these stocks is deviating from the norm in today's session.
Tue, Apr 14, 2026 5:00 PM
-
This Tesla Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Tue, Apr 14, 2026 7:56 AM
-
Undercovered Dozen: Zscaler, Aeluma, Devon Energy And More
Mon, Apr 13, 2026 11:04 PM
-
Which stocks are moving on Monday?
Mon, Apr 13, 2026 7:00 PM
-
Health Care Gains Limited By Cyclical Bias - Health Care Roundup
Mon, Apr 13, 2026 5:18 PM
-
What's going on in today's session
Mon, Apr 13, 2026 4:30 PM
-
These stocks are gapping in today's session
Mon, Apr 13, 2026 2:30 PM
-
FDA Rejection Sparks Questions On Replimune Drug Approval Path
Mon, Apr 13, 2026 1:44 PM
-
12 Health Care Stocks Moving In Monday's Intraday Session
Mon, Apr 13, 2026 1:05 PM
-
Crude Oil Gains 5%; Fastenal Shares Fall After Q1 Earnings
Mon, Apr 13, 2026 12:36 PM
Key Financials
Financial data not available
